GlobalRPh RX List - ZYKADIA
- Product / population
- Oral ceritinib; selected source renal data, not confirmation of current commercial availability.
- Renal measure
- Cockcroft-Gault creatinine clearance, mL/min.
RX mirror: this is not independent corroboration of its underlying label. Check dated-label and formulation limitations.
Renal dosing, restrictions and evidence limits
Mild/moderate impairment, defined in the source analysis as Cockcroft-Gault CrCl 30 to below 90 mL/min, did not materially affect exposure. Severe impairment below 30 was not studied. This does not establish a dialysis regimen or a dose calculated from renal clearance. Confirm the exact available product and oncology regimen separately.